Prefrontal and monoaminergic contributions to stop-signal task performance in rats

Journal of Neuroscience

Volumn 31, Issue 25, 2011, Pages 9254-9263

  Bari, Andrea ^a   Mar, Adam C ^a   Theobald, David E ^a   Elands, Sophie A ^a   Oganya, Kelechi C N A ^a   Eagle, Dawn M ^a   Robbins, Trevor W ^a  

^a UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; DOPAMINE RECEPTOR; FLUPENTIXOL; GUANFACINE; MUSCIMOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DORSAL PRELIMBIC CORTEX; MALE; MONOAMINERGIC SYSTEM; NERVE CELL NETWORK; NEUROANATOMY; NEUROCHEMISTRY; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC TRANSMISSION; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; RAT; RESPONSE INHIBITION; RESPONSE TIME; STOG SIGNAL TASK; TASK PERFORMANCE;

ANIMALS; BIOGENIC MONOAMINES; IMPULSIVE BEHAVIOR; MALE; NEURAL INHIBITION; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; RATS;

EID: 79959682631     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1543-11.2011     Document Type: Article

References (100)

1. Aoki C, Venkatesan C, Go CG, Forman R, Kurose H (1998) Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cereb Cortex 8:269-277.
2. Arnsten AF, Goldman-Rakic PS (1984) Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey. Brain Res 306:9-18.
3. Arnsten AF, Pliszka SR (2011) Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacol Biochem Behav. Advanced online publication. Retrieved May 26, 2011. doi:10.1016/j.pbb.2011.01.020.
4. Aron AR, Robbins TW, Poldrack RA (2004) Inhibition and the right inferior frontal cortex. Trends Cogn Sci 8:170-177.
5. Aron AR, Behrens TE, Smith S, Frank MJ, Poldrack RA (2007) Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI. J Neurosci 27:3743-3752.
6. Aston-Jones G, Cohen JD (2005a) Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol 493:99-110.
7. Aston-Jones G, Cohen JD (2005b) An integrative theory of locus coeruleusnorepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 28:403- 450.
8. Band GP, van der Molen MW, Logan GD (2003) Horse-race model simulations of the stop-signal procedure. Acta Psychol (Amst) 112:105-142.
9. Bari A, Robbins TW (2011) Animal models of ADHD. Curr Top Behav Neurosci 7:149-185.
10. Bari A, Eagle DM, Theobald DE, Robbins TW (2007) Role of dorso-medial prefrontal cortex in behavioural inhibition in rats. Soc Neurosci Abstr 33:741.13.
11. Bari A, Eagle DM, Mar AC, Robinson ES, Robbins TW (2009) Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology 205:273-283.
12. Berridge CW, Waterhouse BD (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33-84.
13. Bondi CO, Jett JD, Morilak DA (2010) Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 34:913-923.
14. Bouret S, Sara SJ (2005) Network reset: a simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci 28:574-582.
15. Broersen LM, Uylings HB (1999) Visual attention task performance in Wistar and Lister hooded rats: response inhibition deficits after medial prefrontal cortex lesions. Neuroscience 94:47-57.
16. Broersen LM, Abbate F, Feenstra MG, de Bruin JP, Heinsbroek RP, Olivier B (2000) Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat. Psychopharmacology (Berl) 149:366-376.
17. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699-711.
18. Cardinal RN, Aitken MRF, eds (2006) ANOVA for the behavioural sciences researcher. Hillsdale, NJ: Erlbaum.
19. Carr DB, Andrews GD, Glen WB, Lavin A (2007) alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents. J Physiol 584:437-450.
20. Cedarbaum JM, Aghajanian GK (1978) Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol 178:1-16.
21. Chamberlain SR, Müller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2006) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311:861- 863.
22. Chamberlain SR, Del Campo N, Dowson J, Müller U, Clark L, Robbins TW, Sahakian BJ (2007) Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 62:977-984.
23. Chamberlain SR, Hampshire A, Müller U, Rubia K, Del Campo N, Craig K, Regenthal R, Suckling J, Roiser JP, Grant JE, Bullmore ET, Robbins TW, Sahakian BJ (2009) Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry 65:550-555.
24. Chambers CD, Bellgrove MA, Stokes MG, Henderson TR, Garavan H, Robertson IH, Morris AP, Mattingley JB (2006) Executive "brake failure" following deactivation of human frontal lobe. J Cogn Neurosci 18:444-455.
25. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714-1723.
26. Corcoran KA, Maren S (2001) Hippocampal inactivation disrupts contextual retrieval of fear memory after extinction. J Neurosci 21:1720-1726.
27. Dalley JW, Stanford SC (1995) Contrasting effects of the imidazol(in)e alpha 2-adrenoceptor agonists, medetomidine, clonidine andUK14,304 on extraneuronal levels of noradrenaline in the rat frontal cortex: evaluation using in vivo microdialysis and synaptosomal uptake studies. Br J Pharmacol 114:1717-1723.
28. Dayan P, Yu AJ (2006) Phasic norepinephrine: a neural interrupt signal for unexpected events. Network 17:335-350.
29. Devauges V, Sara SJ (1990) Activation of the noradrenergic system facilitates an attentional shift in the rat. Behav Brain Res 39:19-28.
30. Devoto P, Flore G, Pani L, Gessa GL (2001) Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry 6:657-664.
31. Duann JR, Ide JS, Luo X, Li CS (2009) Functional connectivity delineates distinct roles of the inferior frontal cortex and presupplementary motor area in stop signal inhibition. J Neurosci 29:10171-10179.
32. Dunn MJ, Killcross S (2006) Differential attenuation of d-amphetamine-induced disruption of conditional discrimination performance by dopamine and serotonin antagonists. Psychopharmacology (Berl) 188:183-192.
33. Eagle DM, Baunez C (2010) Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 34:50-72.
34. Eagle DM, Robbins TW (2003a) Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. Behav Neurosci 117:1302-1317.
35. Eagle DM, Robbins TW (2003b) Lesions of the medial prefrontal cortex or nucleus accumbens core do not impair inhibitory control in rats performing a stop-signal reaction time task. Behav Brain Res 146:131-144.
36. Eagle DM, Tufft MR, Goodchild HL, Robbins TW (2007) Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) 192:193-206.
37. Eagle DM, Bari A, Robbins TW (2008a) The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology 199:439-456.
38. Eagle DM, Baunez C, Hutcheson DM, Lehmann O, Shah AP, Robbins TW (2008b) Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex 18:178-188.
39. Eagle DM, Wong JC, Allan ME, Mar AC, Theobald DE, Robbins TW (2011) Contrasting roles for dopamine D1- and D2-receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J Neurosci 31:7349-7356.
40. Easton N, Marshall F, Fone K, Marsden C (2007) Atomoxetine produces changes in cortico-basal thalamic loop circuits: assessed by phMRI BOLD contrast. Neuropharmacology 52:812-826.
41. Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Glatt SJ (2005) Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis. Behav Brain Funct 1:16.
42. Feil J, Sheppard D, Fitzgerald PB, Yücel M, Lubman DI, Bradshaw JL (2010) Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci Biobehav Rev 35:248-275.
43. Floresco SB, Jentsch JD (2011) Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology 36:227-250.
44. Foote SL, Morrison JH (1987) Extrathalamic modulation of cortical function. Annu Rev Neurosci 10:67-95.
45. Gabbott PL, Warner TA, Jays PR, Salway P, Busby SJ (2005) Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J Comp Neurol 492:145-177.
46. Gamo NJ, Wang M, Arnsten AF (2010) Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry 49:1011-1023.
47. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 65:111-116.
48. Hayton SJ, Lovett-Barron M, Dumont EC, Olmstead MC (2010) Targetspecific encoding of response inhibition: increased contribution of AMPAtoNMDAreceptors at excitatory synapses in the prefrontal cortex. J Neurosci 30:11493-11500.
49. Heidbreder CA, Groenewegen HJ (2003) The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 27:555-579.
50. Hoover WB, Vertes RP (2007) Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct Funct 212:149-179.
51. Howell DC, ed (1997) Statistical methods for psychology, Ed 4. Belmont, CA: Duxbury.
52. Ihalainen JA, Tanila H (2002) In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse prefrontal cortex. Eur J Neurosci 15:1789-1794.
53. Ishikawa A, Ambroggi F, Nicola SM, Fields HL (2008a) Contributions of the amygdala and medial prefrontal cortex to incentive cue responding. Neuroscience 155:573-584.
54. Ishikawa A, Ambroggi F, Nicola SM, Fields HL (2008b) Dorsomedial prefrontal cortex contribution to behavioral and nucleus accumbens neuronal responses to incentive cues. J Neurosci 28:5088-5098.
55. Ji XH, Ji JZ, Zhang H, Li BM (2008) Stimulation of alpha2-adrenoceptors suppresses excitatory synaptic transmission in the medial prefrontal cortex of rat. Neuropsychopharmacology 33:2263-2271.
56. Jodo E, Chiang C, Aston-Jones G (1998) Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience 83:63-79.
57. Jodo E, Suzuki Y, Kayama Y (2000) Selective responsiveness of medial prefrontal cortex neurons to the meaningful stimulus with a low probability of occurrence in rats. Brain Res 856:68-74.
58. Kim J, Ragozzino ME (2005) The involvement of the orbitofrontal cortex in learning under changing task contingencies. Neurobiol Learn Mem 83:125-133.
59. Lapiz MD, Morilak DA (2006) Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137:1039-1049.
60. Lipszyc J, Schachar R (2010) Inhibitory control and psychopathology: a meta-analysis of studies using the stop signal task. J Int Neuropsychol Soc 16:1064-1076.
61. Logan GD (1994) On the ability to inhibit thought and action. A users' guide to the stop signal paradigm. In: Inhibitory processes in attention, memory and language. (Dagenbach D, Carr TH, eds), pp 189-236. San Diego: Academic.
62. Lomber SG (1999) The advantages and limitations of permanent or reversible deactivation techniques in the assessment of neural function. J Neurosci Methods 86:109-117.
63. Loughlin SE, Foote SL, Fallon JH (1982) Locus coeruleus projections to cortex: topography, morphology and collateralization. Brain Res Bull 9:287-294.
64. Luppi PH, Aston-Jones G, Akaoka H, Chouvet G, Jouvet M (1995) Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgaris leucoagglutinin. Neuroscience 65:119-160.
65. Martin JH, Ghez C (1999) Pharmacological inactivation in the analysis of the central control of movement. J Neurosci Methods 86:145-159.
66. Milstein JA, Lehmann O, Theobald DE, Dalley JW, Robbins TW (2007) Selective depletion of cortical noradrenaline by anti-dopamine betahydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat. Psychopharmacology (Berl) 190:51-63.
67. Morón JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22:389-395.
68. Morrison JH, Molliver ME, Grzanna R, Coyle JT (1979) Noradrenergic innervation patterns in three regions of medial cortex: an immunofluorescence characterization. Brain Res Bull 4:849-857.
69. Muller U, Clark L, Lam ML, Moore RM, Murphy CL, Richmond NK, Sandhu RS, Wilkins IA, Menon DK, Sahakian BJ, Robbins TW (2005) Lack of effects of guanfacine on executive and memory functions in healthy male volunteers. Psychopharmacology (Berl) 182:205-213.
70. Murrin LC (1983) Characteristics of 3H-cis-flupenthixol binding in rat striatum. Life Sci 33:2179-2186.
71. Nami R, Bianchini C, Fiorella G, Chierichetti SM, Gennari C (1983) Comparison of effects of guanfacine and clonidine on blood pressure, heart rate, urinary catecholamines, and cyclic nucleotides during and after administration to patients with mild to moderate hypertension. J Cardiovasc Pharmacol 5:546-551.
72. Naneix F, Marchand AR, Di Scala G, Pape JR, Coutureau E (2009) A role for medial prefrontal dopaminergic innervation in instrumental conditioning. J Neurosci 29:6599-6606.
73. Narayanan NS, Laubach M (2006) Top-down control of motor cortex ensembles by dorsomedial prefrontal cortex. Neuron 52:921-931.
74. Narayanan NS, Horst NK, Laubach M (2006) Reversible inactivations of rat medial prefrontal cortex impair the ability to wait for a stimulus. Neuroscience 139:865-876.
75. Overtoom CC, Verbaten MN, Kemner C, Kenemans JL, van Engeland H, Buitelaar JK, van der Molen MW, van der Gugten J, Westenberg H, Maes RA, Koelega HS (2003) Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with attention deficit hyperactivity disorder. Behav Brain Res 145:7-15.
76. Park WK, Bari AA, Jey AR, Anderson SM, Spealman RD, Rowlett JK, Pierce RC (2002) Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci 22:2916-2925.
77. Pattij T, Vanderschuren LJ (2008) The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29:192-199.
78. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, Ed 2. Sidney: Academic.
79. Ragozzino ME, Rozman S (2007) The effect of rat anterior cingulate inactivation on cognitive flexibility. Behav Neurosci 121:698-706.
80. Risterucci C, Terramorsi D, Nieoullon A, Amalric M (2003) Excitotoxic lesions of the prelimbic-infralimbic areas of the rodent prefrontal cortex disrupt motor preparatory processes. Eur J Neurosci 17:1498-1508.
81. Robbins TW (2005) Controlling stress: how the brain protects itself from depression. Nat Neurosci 8:261-262.
82. Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of frontoexecutive function: monoaminergic modulation. Annu Rev Neurosci 32:267-287.
83. Robbins TW, Giardini V, Jones GH, Reading P, Sahakian BJ (1990) Effects of dopamine depletion from the caudate-putamen and nucleus accumbens septi on the acquisition and performance of a conditional discrimination task. Behav Brain Res 38:243-261.
84. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, Dalley JW, Robbins TW (2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33:1028-1037.
85. Saameli K, Jerie P, Scholtysik G (1982) Guanfacine and other centrally acting drugs in antihypertensive therapy; pharmacological and clinical aspects. Clin Exp Hypertens A 4:209-219.
86. Samuels ER, Szabadi E (2008) Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function. I. Principles of functional organisation. Curr Neuropharmacol 6:235-253.
87. Schilman EA, Uylings HB, Galis-de Graaf Y, Joel D, Groenewegen HJ (2008) The orbital cortex in rats topographically projects to central parts of the caudate-putamen complex. Neurosci Lett 432:40-45.
88. Scholtysik G, Lauener H, Eichenberger E, Bürki H, Salzmann R, Müller-Schweinitzer E, Waite R (1975) Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141). Arzneimittelforschung 25:1483-1491.
89. Sesack SR, Hawrylak VA, Guido MA, Levey AI (1998) Cellular and subcellular localization of the dopamine transporter in rat cortex. Adv Pharmacol 42:171-174.
90. Souza MM, Mello e Souza T, Vinadé ER, Rodrigues C, Choi HK, Dedavide Silva TL, Medina JH, Izquierdo I (2002) Effects of posttraining treatments in the posterior cingulate cortex on short- and long-term memory for inhibitory avoidance in rats. Neurobiol Learn Mem 77:202-210.
91. Tanda G, Pontieri FE, Frau R, Di Chiara G (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-2085.
92. Tannock R, Schachar RJ, Carr RP, Chajczyk D, Logan GD (1989) Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol 17:473-491.
93. Uhlén S, Wikberg JE (1991) Delineation of rat kidney alpha 2A- and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an alpha 2A-selective compound. Eur J Pharmacol 202:235-243.
94. Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G (1999) The role of locus coeruleus in the regulation of cognitive performance. Science 283:549-554.
95. van Duuren E, van der Plasse G, van der Blom R, Joosten RN, Mulder AB, Pennartz CM, Feenstra MG (2007) Pharmacological manipulation of neuronal ensemble activity by reverse microdialysis in freely moving rats: a comparative study of the effects of tetrodotoxin, lidocaine, and muscimol. J Pharmacol Exp Ther 323:61-69.
96. van Veldhuizen MJ, Feenstra MG, Heinsbroek RP, Boer GJ (1993) In vivo microdialysis of noradrenaline overflow: effects of alpha-adrenoceptor agonists and antagonists measured by cumulative concentrationresponse curves. Br J Pharmacol 109:655-660.
97. Vertes RP (2006) Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 142:1-20.
98. Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A, Vijayraghavan S, Brennan A, Dudley A, Nou E, Mazer JA, McCormick DA, Arnsten AF (2007) Alpha2A-adrenoceptors strengthen workingmemory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 129:397-410.
99. Zandbelt BB, Vink M (2010) On the role of the striatum in response inhibition. PLoS One 5:e13848.
100. Zhu Y, Aston-Jones G (1996) The medial prefrontal cortex prominently innervates a peri-locus coeruleus dendritic zone in the rat. Soc Neurosci Abstr 22:601.